211 related articles for article (PubMed ID: 23369356)
21. Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy.
Hardman C; Ho S; Shimizu A; Luu-Nguyen Q; Sloane JL; Soliman MSA; Marsden MD; Zack JA; Wender PA
Nat Commun; 2020 Apr; 11(1):1879. PubMed ID: 32312992
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and Biological Evaluation of Several Bryostatin Analogues Bearing a Diacylglycerol Lactone C-Ring.
Baumann DO; McGowan KM; Kedei N; Peach ML; Blumberg PM; Keck GE
J Org Chem; 2016 Sep; 81(17):7862-83. PubMed ID: 27494208
[TBL] [Abstract][Full Text] [Related]
23. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha.
Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM
Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294
[TBL] [Abstract][Full Text] [Related]
24. Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism.
De Lorenzo MS; Yamaguchi K; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2003 Oct; 9(13):5036-43. PubMed ID: 14581379
[TBL] [Abstract][Full Text] [Related]
25. Comparison of transcriptional response to phorbol ester, bryostatin 1, and bryostatin analogs in LNCaP and U937 cancer cell lines provides insight into their differential mechanism of action.
Kedei N; Telek A; Michalowski AM; Kraft MB; Li W; Poudel YB; Rudra A; Petersen ME; Keck GE; Blumberg PM
Biochem Pharmacol; 2013 Feb; 85(3):313-24. PubMed ID: 23146662
[TBL] [Abstract][Full Text] [Related]
26. Toward a biorelevant structure of protein kinase C bound modulators: design, synthesis, and evaluation of labeled bryostatin analogues for analysis with rotational echo double resonance NMR spectroscopy.
Loy BA; Lesser AB; Staveness D; Billingsley KL; Cegelski L; Wender PA
J Am Chem Soc; 2015 Mar; 137(10):3678-85. PubMed ID: 25710634
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic Bryostatin Derivatives from the South China Sea Bryozoan Bugula neritina.
Yu HB; Yang F; Li YY; Gan JH; Jiao WH; Lin HW
J Nat Prod; 2015 May; 78(5):1169-73. PubMed ID: 25932671
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin.
Irie K; Yanagita RC
Chem Rec; 2014 Apr; 14(2):251-67. PubMed ID: 24677503
[TBL] [Abstract][Full Text] [Related]
29. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z; Denning MF; Smith CB; Dlugosz AA; Yuspa SH; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Nov; 46(5):840-50. PubMed ID: 7969070
[TBL] [Abstract][Full Text] [Related]
30. Bryostatins selectively regulate protein kinase C-mediated effects on GH4 cell proliferation.
Mackanos EA; Pettit GR; Ramsdell JS
J Biol Chem; 1991 Jun; 266(17):11205-12. PubMed ID: 1904062
[TBL] [Abstract][Full Text] [Related]
31. Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes.
Kazanietz MG; Lewin NE; Gao F; Pettit GR; Blumberg PM
Mol Pharmacol; 1994 Aug; 46(2):374-9. PubMed ID: 8078499
[TBL] [Abstract][Full Text] [Related]
32. Function oriented synthesis: the design, synthesis, PKC binding and translocation activity of a new bryostatin analog.
Wender PA; Baryza JL; Brenner SE; Clarke MO; Craske ML; Horan JC; Meyer T
Curr Drug Discov Technol; 2004 Jan; 1(1):1-11. PubMed ID: 16472215
[TBL] [Abstract][Full Text] [Related]
33. Binding of [3H]bryostatin 4 to protein kinase C.
Lewin NE; Dell'Aquila ML; Pettit GR; Blumberg PM; Warren BS
Biochem Pharmacol; 1992 May; 43(9):2007-14. PubMed ID: 1596288
[TBL] [Abstract][Full Text] [Related]
34. Total synthesis of bryostatin 3.
Trost BM; Wang Y; Buckl AK; Huang Z; Nguyen MH; Kuzmina O
Science; 2020 May; 368(6494):1007-1011. PubMed ID: 32467391
[TBL] [Abstract][Full Text] [Related]
35. Structure of bryostatin 20: a symbiont-produced chemical defense for larvae of the host bryozoan, Bugula neritina.
Lopanik N; Gustafson KR; Lindquist N
J Nat Prod; 2004 Aug; 67(8):1412-4. PubMed ID: 15332866
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.
Staveness D; Abdelnabi R; Near KE; Nakagawa Y; Neyts J; Delang L; Leyssen P; Wender PA
J Nat Prod; 2016 Apr; 79(4):680-4. PubMed ID: 26900711
[TBL] [Abstract][Full Text] [Related]
37. The rational design of potential chemotherapeutic agents: synthesis of bryostatin analogues.
Wender PA; Hinkle KW; Koehler MF; Lippa B
Med Res Rev; 1999 Sep; 19(5):388-407. PubMed ID: 10502742
[TBL] [Abstract][Full Text] [Related]
38. Delta-protein kinase C phosphorylation parallels inhibition of nerve growth factor-induced differentiation independent of changes in Trk A and MAP kinase signalling in PC12 cells.
Wooten MW; Seibenhener ML; Heikkila JE; Mischak H
Cell Signal; 1998 Apr; 10(4):265-76. PubMed ID: 9617484
[TBL] [Abstract][Full Text] [Related]
39. New approaches to the total synthesis of the bryostatin antitumor macrolides.
Hale KJ; Manaviazar S
Chem Asian J; 2010 Apr; 5(4):704-54. PubMed ID: 20354984
[TBL] [Abstract][Full Text] [Related]
40. Bryostatin 1 modulates beta-catenin subcellular localization and transcription activity through protein kinase D1 activation.
Jaggi M; Chauhan SC; Du C; Balaji KC
Mol Cancer Ther; 2008 Sep; 7(9):2703-12. PubMed ID: 18765827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
